Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Endocyte Inc (NASDAQ:ECYT)

1.47
Delayed Data
As of Jul 26
 -0.06 / -3.92%
Today’s Change
1.36
Today|||52-Week Range
3.49
-42.35%
Year-to-Date

Today’s Trading

Previous close1.53
Today’s open1.53
Day’s range1.46 - 1.53
Volume473,658
Average volume (3 months)536,906
Market cap$65.0M
Dividend yield--
Data as of 07/26/2017

Growth & Valuation

Earnings growth (last year)-6.12%
Earnings growth (this year)+14.90%
Earnings growth (next 5 years)--
Revenue growth (last year)0.00%
P/E ratioNM
Price/Sales1,537.67
Price/Book0.47

Competitors

 Today’s
change
Today’s
% change
NOVNNovan Inc+0.13+3.22%
SYNSynthetic Biologics ...-0.02-3.29%
PTNPalatin Technologies...+0.00+0.67%
RNNRexahn Pharmaceutica...+0.07+3.05%
Data as of 07/26/2017

Financials

Next reporting dateAugust 3, 2017
EPS forecast (this quarter)-$0.25
Annual revenue (last year)$70.0K
Annual profit (last year)-$43.9M
Net profit margin-62,696.53%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Michael A. Sherman
Chief Financial Officer
Michael T. Andriole
Corporate headquarters
West Lafayette, Indiana

Forecasts